Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
about
Unrevealed mosaicism in the next-generation sequencing eraEosinophilia Associated with Disorders of Immune Deficiency or Immune DysregulationMendelian genetics of human susceptibility to fungal infectionAdvances in basic and clinical immunology in 2013A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.HSP and deafness: Neurocristopathy caused by a novel mosaic SOX10 mutation.STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and functionIL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype.Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variabilityThe Ying and Yang of STAT3 in Human DiseaseComparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency.B cell biology: an overview.Genetic Predictors of Susceptibility to Dermatophytoses.Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.Somatic mosaicism in B cells of a patient with autosomal dominant hyper IgE syndrome.TH17 Cells in STAT3 Related Hyper-IgE Syndrome.Prolonging culture of primary human keratinocytes isolated from suction blisters with the Rho kinase inhibitor Y-27632
P2860
Q26781758-B13F002D-35E3-4F56-BB62-95DDE77D1E46Q26799603-0D0AF5FE-8A1F-4EFC-817F-DFABBBD7D9C7Q27022250-7495F591-B5CD-40BC-81B3-8A9F653C6348Q27027001-B40424E0-A691-4858-BE5B-20A64BA822C3Q33585268-C627EE6E-85E9-4580-A8A2-FB21A4E536F0Q33689173-0783DAC7-D2D1-448D-BE3B-760893F15F35Q35671239-411CAD49-19C3-491F-B421-902CE03C9DB4Q35858596-AFAC7B7B-92E7-4A16-B27C-991E533DAEF8Q36148136-8C97643F-EA33-4052-8164-38E6971D1220Q36236873-942FE7D1-9201-4204-84C7-D88A401CD351Q37698945-F1D58660-D5F6-462E-8F6D-669448EF3ABEQ38196333-FB0057BE-91B0-4E0B-873B-B4BF4942CAF2Q39511094-FAD556D9-7738-4330-A0BF-DE6BE853712BQ42231843-25C4F49E-C610-4F67-BAF0-0CF6BD861DFBQ50632119-F1AE4E29-D3B6-4163-963C-BA1AE0E8CA35Q54303931-24843625-014C-4001-9041-22D780A2A205Q58748112-0DA540AD-EE04-4230-9DF9-ACA674797297
P2860
Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@ast
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@en
type
label
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@ast
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@en
prefLabel
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@ast
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@en
P2093
P2860
P1476
Intermediate phenotypes in pat ...... e caused by somatic mosaicism.
@en
P2093
Alexandra F Freeman
Carolyn J Henderson
Douglas B Kuhns
Jennifer M Puck
John I Gallin
Joie Davis
Joshua D Milner
Kathryn J Sowerwine
Kol A Zarember
P2860
P304
P356
10.1016/J.JACI.2013.02.038
P407
P577
2013-04-25T00:00:00Z